Other Links
Research and Development
Generic or “Generic Plus” products undergo clinical trials in the form of pharmacokinetic studies on human subjects in order to demonstrate therapeutic equivalence.
The company’s Clinical Operations Department has demonstrated a record in the selection of accredited Clinical Research Organizations (CROs).
The department also excels in designing, planning, and executing clinical trials to demonstrate bioequivalence of the generic drug to the branded counterpart in addition to ensuring compliance with regulatory requirements including compliance with Good Clinical Practice (GCP) through audits of CROs and respective clinical trials.
